EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis

Detalhes bibliográficos
Autor(a) principal: Fokkens, W
Data de Publicação: 2019
Outros Autores: Desrosiers, M, Harvey, R, Hopkins, C, Mullol, J, Philpott, C, Alobid, I, Lima, W T Anselmo, Bachert, Claus, Baroody, F, Bernal-Sprekelsen, M, von Buchwald, C, Cervin, A, Cohen, Noam, Constantinidis, J., De Gabory, L., Douglas, R, Gevaert, P, Hafner, A, Hellings, Peter, Joos, G, Kalogjera, L, Kern, R, Knill, A, Kocks, J, Landis, Basile, Limpens, J., Lebeer, S, Lourenço, Olga, Matricardi, P M, Meco, C, O Mahony, L., Reitsma, S, Ryan, D, Schlosser, R, Senior, B, Smith, T, Teeling, T., Tomazic, Peter Valentin, Toppila-Salmi, S, Wang, D Y, Wang, D, Zhang, L, Lund, V
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.6/9360
Resumo: Background: The European Position Papers on Rhinosinusitis from 2005, 2007 and 2012 have had a measurable impact on the way this common condition with high impact on quality of life is managed around the world. EPOS2020 will be the latest iteration of the guideline, addressing new stakeholders and target users, presenting a summary of the latest literature and evolving treatment modalities, and formulating clear recommendations based on all available evidence. Methodology: Based on the AGREE II framework, this article demonstrates how the EPOS2020 steering group will address six key areas to ensure consistency in quality and presentation of information in the latest rhinosinusitis clinical practice guideline: scope and purpose; stakeholder involvement; rigour of development; clarity of presentation; recommendations and applicability; editorial independence. Results: By analysing the guidance from AGREE II, we formulated a detailed development strategy for EPOS2020. We identify new stakeholders and target users and ratify the importance of patient involvement in the latest EPOS guideline. New and expanded areas of research to be addressed are highlighted. We confirm our intention to use mixed methodologies, combining evidencebased medicine with real life studies; when no evidence can be found, use Delphi rounds to achieve clear, inclusive recommendations. We also introduce new concepts for dissemination of the guideline, using Internet and social media to improve accessibility. Conclusion: This article is an introduction to the EPOS2020 project, and presents the key goals, core stakeholders, planned methodology and dissemination strategies for the latest version of this influential guideline.
id RCAP_140eacc8cc37dde7efea4b9c6770972d
oai_identifier_str oai:ubibliorum.ubi.pt:10400.6/9360
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling EPOS2020: development strategy and goals for the latest European Position Paper on RhinosinusitisEvidence-Based MedicineHumansPatient ParticipationGoalsQuality of LifeRhinitisSinusitisBackground: The European Position Papers on Rhinosinusitis from 2005, 2007 and 2012 have had a measurable impact on the way this common condition with high impact on quality of life is managed around the world. EPOS2020 will be the latest iteration of the guideline, addressing new stakeholders and target users, presenting a summary of the latest literature and evolving treatment modalities, and formulating clear recommendations based on all available evidence. Methodology: Based on the AGREE II framework, this article demonstrates how the EPOS2020 steering group will address six key areas to ensure consistency in quality and presentation of information in the latest rhinosinusitis clinical practice guideline: scope and purpose; stakeholder involvement; rigour of development; clarity of presentation; recommendations and applicability; editorial independence. Results: By analysing the guidance from AGREE II, we formulated a detailed development strategy for EPOS2020. We identify new stakeholders and target users and ratify the importance of patient involvement in the latest EPOS guideline. New and expanded areas of research to be addressed are highlighted. We confirm our intention to use mixed methodologies, combining evidencebased medicine with real life studies; when no evidence can be found, use Delphi rounds to achieve clear, inclusive recommendations. We also introduce new concepts for dissemination of the guideline, using Internet and social media to improve accessibility. Conclusion: This article is an introduction to the EPOS2020 project, and presents the key goals, core stakeholders, planned methodology and dissemination strategies for the latest version of this influential guideline.uBibliorumFokkens, WDesrosiers, MHarvey, RHopkins, CMullol, JPhilpott, CAlobid, ILima, W T AnselmoBachert, ClausBaroody, FBernal-Sprekelsen, Mvon Buchwald, CCervin, ACohen, NoamConstantinidis, J.De Gabory, L.Douglas, RGevaert, PHafner, AHellings, PeterJoos, GKalogjera, LKern, RKnill, AKocks, JLandis, BasileLimpens, J.Lebeer, SLourenço, OlgaMatricardi, P MMeco, CO Mahony, L.Reitsma, SRyan, DSchlosser, RSenior, BSmith, TTeeling, T.Tomazic, Peter ValentinToppila-Salmi, SWang, D YWang, DZhang, LLund, V2020-02-19T11:24:09Z2019-06-012019-06-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.6/9360eng10.4193/Rhin17.253metadata only accessinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-02-21T03:39:07Zoai:ubibliorum.ubi.pt:10400.6/9360Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T00:49:30.078458Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
title EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
spellingShingle EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
Fokkens, W
Evidence-Based Medicine
Humans
Patient Participation
Goals
Quality of Life
Rhinitis
Sinusitis
title_short EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
title_full EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
title_fullStr EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
title_full_unstemmed EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
title_sort EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
author Fokkens, W
author_facet Fokkens, W
Desrosiers, M
Harvey, R
Hopkins, C
Mullol, J
Philpott, C
Alobid, I
Lima, W T Anselmo
Bachert, Claus
Baroody, F
Bernal-Sprekelsen, M
von Buchwald, C
Cervin, A
Cohen, Noam
Constantinidis, J.
De Gabory, L.
Douglas, R
Gevaert, P
Hafner, A
Hellings, Peter
Joos, G
Kalogjera, L
Kern, R
Knill, A
Kocks, J
Landis, Basile
Limpens, J.
Lebeer, S
Lourenço, Olga
Matricardi, P M
Meco, C
O Mahony, L.
Reitsma, S
Ryan, D
Schlosser, R
Senior, B
Smith, T
Teeling, T.
Tomazic, Peter Valentin
Toppila-Salmi, S
Wang, D Y
Wang, D
Zhang, L
Lund, V
author_role author
author2 Desrosiers, M
Harvey, R
Hopkins, C
Mullol, J
Philpott, C
Alobid, I
Lima, W T Anselmo
Bachert, Claus
Baroody, F
Bernal-Sprekelsen, M
von Buchwald, C
Cervin, A
Cohen, Noam
Constantinidis, J.
De Gabory, L.
Douglas, R
Gevaert, P
Hafner, A
Hellings, Peter
Joos, G
Kalogjera, L
Kern, R
Knill, A
Kocks, J
Landis, Basile
Limpens, J.
Lebeer, S
Lourenço, Olga
Matricardi, P M
Meco, C
O Mahony, L.
Reitsma, S
Ryan, D
Schlosser, R
Senior, B
Smith, T
Teeling, T.
Tomazic, Peter Valentin
Toppila-Salmi, S
Wang, D Y
Wang, D
Zhang, L
Lund, V
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv uBibliorum
dc.contributor.author.fl_str_mv Fokkens, W
Desrosiers, M
Harvey, R
Hopkins, C
Mullol, J
Philpott, C
Alobid, I
Lima, W T Anselmo
Bachert, Claus
Baroody, F
Bernal-Sprekelsen, M
von Buchwald, C
Cervin, A
Cohen, Noam
Constantinidis, J.
De Gabory, L.
Douglas, R
Gevaert, P
Hafner, A
Hellings, Peter
Joos, G
Kalogjera, L
Kern, R
Knill, A
Kocks, J
Landis, Basile
Limpens, J.
Lebeer, S
Lourenço, Olga
Matricardi, P M
Meco, C
O Mahony, L.
Reitsma, S
Ryan, D
Schlosser, R
Senior, B
Smith, T
Teeling, T.
Tomazic, Peter Valentin
Toppila-Salmi, S
Wang, D Y
Wang, D
Zhang, L
Lund, V
dc.subject.por.fl_str_mv Evidence-Based Medicine
Humans
Patient Participation
Goals
Quality of Life
Rhinitis
Sinusitis
topic Evidence-Based Medicine
Humans
Patient Participation
Goals
Quality of Life
Rhinitis
Sinusitis
description Background: The European Position Papers on Rhinosinusitis from 2005, 2007 and 2012 have had a measurable impact on the way this common condition with high impact on quality of life is managed around the world. EPOS2020 will be the latest iteration of the guideline, addressing new stakeholders and target users, presenting a summary of the latest literature and evolving treatment modalities, and formulating clear recommendations based on all available evidence. Methodology: Based on the AGREE II framework, this article demonstrates how the EPOS2020 steering group will address six key areas to ensure consistency in quality and presentation of information in the latest rhinosinusitis clinical practice guideline: scope and purpose; stakeholder involvement; rigour of development; clarity of presentation; recommendations and applicability; editorial independence. Results: By analysing the guidance from AGREE II, we formulated a detailed development strategy for EPOS2020. We identify new stakeholders and target users and ratify the importance of patient involvement in the latest EPOS guideline. New and expanded areas of research to be addressed are highlighted. We confirm our intention to use mixed methodologies, combining evidencebased medicine with real life studies; when no evidence can be found, use Delphi rounds to achieve clear, inclusive recommendations. We also introduce new concepts for dissemination of the guideline, using Internet and social media to improve accessibility. Conclusion: This article is an introduction to the EPOS2020 project, and presents the key goals, core stakeholders, planned methodology and dissemination strategies for the latest version of this influential guideline.
publishDate 2019
dc.date.none.fl_str_mv 2019-06-01
2019-06-01T00:00:00Z
2020-02-19T11:24:09Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.6/9360
url http://hdl.handle.net/10400.6/9360
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.4193/Rhin17.253
dc.rights.driver.fl_str_mv metadata only access
info:eu-repo/semantics/openAccess
rights_invalid_str_mv metadata only access
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799136387051552768